Formed in 2024 by ADQ, a sovereign wealth fund, Arcera consolidates several pharmaceutical businesses, including Acino ...

A clinical-stage biotech company developing off-the-shelf, genetically unmodified T cell therapeutics for infectious diseases ...

Notable research news last week included US biopharma Avidity Biosciences announcing a positive update on its muscular ...